Guardian Pharmacy executive reports equity holdings
Guardian Pharmacy Services, Inc. executive Chris Crisafulli reports existing equity holdings in a Form 3 filing.
Rhea-AI Filing Summary
Guardian Pharmacy Services, Inc. executive Chris Crisafulli reports existing equity holdings in a Form 3 filing. The filing lists 55,469 shares of Class A common stock held directly and 18,931 shares of Class B common stock that convert into Class A on a one-for-one basis on September 27, 2026.
The report also discloses equity-based awards: 7,594 and 4,476 restricted stock units that vest on February 14, 2028 and March 1, 2029, respectively, settling in Class A shares, plus a stock option for 25,000 Class A shares at an exercise price of $34.59 per share that vests in full on February 11, 2029 and expires on February 11, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Crisafulli Chris
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Class B Common Stock | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class B Common Stock — 18,931 contracts (Direct);
Stock Option (right to buy) — 25,000 contracts (Direct);
Class A Common Stock — 55,469 shares (Direct)
Footnotes (3)
- F1. Also includes 7,594 and 4,476 restricted stock units that, upon vesting in full on February 14, 2028 and March 1, 2029, respectively, are settled on a one-for-one basis in shares of Guardian Pharmacy Services, Inc.'s (the "Issuer") Class A common stock.
- F2. Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of the Issuer's Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.
- F3. This option shall vest and become exercisable in full on February 11, 2029.
Key Figures
Direct Class A shares: 55,469 shares
Class B shares (convertible): 18,931 shares
Stock option underlying shares: 25,000 shares
+5 more
8 metrics
Direct Class A shares
55,469 shares
Direct Class A common stock holding reported for Chris Crisafulli
Class B shares (convertible)
18,931 shares
Class B common stock automatically converts 1:1 into Class A on September 27, 2026
Stock option underlying shares
25,000 shares
Class A shares underlying option held by Crisafulli
Option exercise price
$34.59 per share
Exercise price for 25,000-share stock option
Option vesting date
February 11, 2029
Date stock option becomes fully exercisable
Option expiration date
February 11, 2036
Expiration date of stock option
RSUs first tranche
7,594 units
RSUs vesting February 14, 2028 into Class A shares
RSUs second tranche
4,476 units
RSUs vesting March 1, 2029 into Class A shares
Key Terms
restricted stock units, Class B common stock, automatically convert, Stock Option (right to buy), +1 more
5 terms
restricted stock units financial
"Also includes 7,594 and 4,476 restricted stock units that, upon vesting in full..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class B common stock financial
"the Reporting Person's shares of the Issuer's Class B common stock automatically convert..."
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
automatically convert financial
"Class B common stock automatically convert into shares of the Issuer's Class A common stock..."
Stock Option (right to buy) financial
"Stock Option (right to buy) underlying Guardian Pharmacy Services, Inc. Class A common stock..."
Amended and Restated Certificate of Incorporation financial
"Pursuant to the Issuer's Amended and Restated Certificate of Incorporation..."
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 for GRDN’s Chris Crisafulli show?
The Form 3 shows Chris Crisafulli’s existing ownership in Guardian Pharmacy Services, Inc., including Class A and Class B common stock, restricted stock units, and a stock option grant, all held directly as part of his equity position in the company.
What GRDN Class B common stock does Chris Crisafulli report?
He reports holdings of 18,931 shares of Guardian Pharmacy Services, Inc. Class B common stock. According to the filing, these Class B shares automatically convert into an equal number of Class A shares on September 27, 2026, based on a one-for-one conversion ratio.
What stock option position in GRDN does Chris Crisafulli have?
Chris Crisafulli holds a stock option covering 25,000 shares of Guardian Pharmacy Services, Inc. Class A common stock at an exercise price of $34.59. The filing states this option vests and becomes fully exercisable on February 11, 2029 and expires on February 11, 2036.
What restricted stock units (RSUs) are disclosed for GRDN’s Chris Crisafulli?
The filing notes 7,594 and 4,476 restricted stock units. Upon full vesting on February 14, 2028 and March 1, 2029, respectively, these RSUs will each settle on a one-for-one basis in Guardian Pharmacy Services, Inc. Class A common stock, increasing his share ownership.
Does the GRDN Form 3 show any recent insider buying or selling?
The Form 3 lists Crisafulli’s holdings but does not report specific buy or sell transactions. Entries are coded as holdings, and the transaction summary shows no categorized purchases, sales, exercises, gifts, or tax withholdings, focusing instead on his existing equity and derivative positions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
